Literature DB >> 10712262

Glucagon-like peptide-2 increases sucrase-isomaltase but not caudal-related homeobox protein-2 gene expression.

P A Kitchen1, A J Fitzgerald, R A Goodlad, N F Barley, M A Ghatei, S Legon, S R Bloom, A Price, J R Walters, A Forbes.   

Abstract

To determine the effect of glucagon-like peptide-2 (GLP-2) on sucrase-isomaltase and caudal-related homeobox protein-2 (Cdx-2) gene expression, male Wistar rats were divided into total parenteral nutrition (TPN)-fed and GLP-2-treated, TPN-fed groups. TPN was given via a jugular line, inserted under anesthesia, for 7 days. The treatment group received 40 microg/day of GLP-2 intravenously with the TPN diet. The small intestine and colon were weighed and measured. Tissue was obtained from the jejunum, terminal ileum, and midcolon. RNA analysis, morphometry, and microdissection were performed. The weight of the small intestine of GLP-2-treated rats was greater than that of TPN-fed rats (P < 0.001). GLP-2 increased the mean metaphase arrests/crypt in both the jejunum and ileum (P < 0.001). Ileal expression of sucrase-isomaltase was increased by 1. 6-fold (P < 0.05). Jejunal expression was increased by a similar amount, although not significantly (P = 0.08). There was no change in Cdx-2 gene expression. Thus GLP-2 can maintain small intestinal morphology and function, but effects on gene expression are not mediated by gross changes in the level of the mRNA for the homeobox protein Cdx-2.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712262     DOI: 10.1152/ajpgi.2000.278.3.G425

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  7 in total

1.  Effect of gastrin on differentiation of rat intestinal epithelial cells in vitro.

Authors:  Zhou Wang; Wei-Wen Chen; Ru-Liu Li; Bin Wen; Jing-Bo Sun
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

2.  Exogenous glucagon-like peptide-2 (GLP-2) augments GLP-2 receptor mRNA and maintains proglucagon mRNA levels in resected rats.

Authors:  Matthew C Koopmann; David W Nelson; Sangita G Murali; Xiaowen Liu; Mark S Brownfield; Jens J Holst; Denise M Ney
Journal:  JPEN J Parenter Enteral Nutr       Date:  2008 May-Jun       Impact factor: 4.016

3.  GLP-2, EGF, and the Intestinal Epithelial IGF-1 Receptor Interactions in the Regulation of Crypt Cell Proliferation.

Authors:  Zivit Fesler; Emilia Mitova; Patricia L Brubaker
Journal:  Endocrinology       Date:  2020-04-01       Impact factor: 4.736

Review 4.  Intestinal hormones and growth factors: effects on the small intestine.

Authors:  Laurie Drozdowski; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2009-01-28       Impact factor: 5.742

5.  Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.

Authors:  P D Cani; S Possemiers; T Van de Wiele; Y Guiot; A Everard; O Rottier; L Geurts; D Naslain; A Neyrinck; D M Lambert; G G Muccioli; N M Delzenne
Journal:  Gut       Date:  2009-02-24       Impact factor: 23.059

6.  Acute Low-Intensity Treadmill Running Upregulates the Expression of Intestinal Glucose Transporters via GLP-2 in Mice.

Authors:  Kai Aoki; Takuji Suzuki; Fang Hui; Takuro Nakano; Koki Yanazawa; Masato Yonamine; Shinichiro Fujita; Takehito Sugasawa; Yasuko Yoshida; Naomi Omi; Yasushi Kawakami; Kazuhiro Takekoshi
Journal:  Nutrients       Date:  2021-05-20       Impact factor: 5.717

Review 7.  The Role of the Gut Microbiota in Lipid and Lipoprotein Metabolism.

Authors:  Yijing Yu; Fitore Raka; Khosrow Adeli
Journal:  J Clin Med       Date:  2019-12-17       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.